{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T03:01:08Z","timestamp":1771210868315,"version":"3.50.1"},"reference-count":49,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare adverse events and flares among different doses and types of COVID\u201019 vaccines in patients with systemic lupus erythematosus (SLE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All consecutive SLE patients in a lupus cohort, seen between March and October 2022, were invited to join this retrospective study. Inclusion criteria were aged \u2265\u200920\u2009years and had received at least one dose of COVID\u201019 vaccine. Data regarding adverse events after vaccination, clinical disease activity and flares within 30\u2009days postvaccination were reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 201 SLE patients received 524 vaccine doses, with 201, 199, and 124 patients received 1, 2, and 3 doses, respectively. The vaccines included inactivated virus vaccine, adenovirus\u2010vectored vaccine, and mRNA vaccines in 183 (35%), 128 (24%), and 213 (41%) doses, respectively. Regardless of the dose and type of vaccine, adverse events occurred in 50%\u201370% of patients. Pain and swelling at the injection site were common local symptoms, whereas constitutional, neurological, musculoskeletal, and mucocutaneous symptoms were among systemic ones. The majority of these symptoms were mild to moderate. Patients reported they had disease flares after vaccination in 5%\u20136%, while actual flares determined by physicians occurred in 8%\u201313% of them, giving fair to moderate rating agreement between patients and physicians (Cohen's kappa: 0.21\u20130.44). There was no significant difference in mean mSLEDAI\u20102K between pre\u2010 and 30\u2009days postvaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adverse events after vaccination were common, regardless of the dose or type of COVID\u201019 vaccines, but only a small proportion of patients had severe symptoms. Flares were uncommon. The rating agreement of flares between patients and physicians as fair to moderate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/1756-185x.70001","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T06:17:02Z","timestamp":1733811422000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["<scp>COVID<\/scp>\n                    \u201019 Vaccination in Patients With Systemic Lupus Erythematosus: Adverse Events and Rating Agreement of Flares Between Patients and Physicians"],"prefix":"10.1111","volume":"27","author":[{"given":"Punsita","family":"Tangkum","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1150-6424","authenticated-orcid":false,"given":"Nuntana","family":"Kasitanon","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanitcha","family":"Gumtorntip","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poramed","family":"Winichakoon","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supparat","family":"Konsamun","sequence":"additional","affiliation":[{"name":"Research Unit, Department of Internal Medicine, Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antika","family":"Wongthanee","sequence":"additional","affiliation":[{"name":"Research Unit, Department of Internal Medicine, Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3105-6122","authenticated-orcid":false,"given":"Worawit","family":"Louthrenoo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"WHO\u201cArchived: WHO Timeline\u2010COVID\u201019 \u201d(2020) https:\/\/www.who.int\/news\/item\/27\u201004\u20102020\u2010who\u2010timeline\u2010\u2010\u2010covid\u201019."},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030682"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S400458"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101084"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106288"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112192"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/v16020203"},{"issue":"10","key":"e_1_2_11_9_1","article-title":"An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management","volume":"14","author":"Ameer M. A.","year":"2022","journal-title":"Cureus"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa478"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06227-7"},{"issue":"1","key":"e_1_2_11_12_1","first-page":"E1","article-title":"American College of Rheumatology Guidance for COVID\u201019 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5","volume":"75","author":"Curtis J. R.","year":"2023","journal-title":"Arthritis & Rhematology"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00221-6"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050663"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221089586"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11091446"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/09612033241232576"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"issue":"10","key":"e_1_2_11_20_1","first-page":"1934","article-title":"The Systemic Lupus Activity Measure\u2010Revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a Modified SLEDAI\u20102K Are Adequate Instruments to Measure Disease Activity in Systemic Lupus Erythematosus","volume":"31","author":"Uribe A. G.","year":"2004","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400506"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05963-6"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04972-7"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24824"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221097"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05980-5"},{"key":"e_1_2_11_28_1","first-page":"1","article-title":"Risk of Disease Flares After SARS\u2010CoV\u20102 mRNA Vaccination in Patients With Systemic Lupus Erythematosus","author":"Kikuchi J.","year":"2024","journal-title":"Immunological Medicine"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10060853"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04938-9"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-000975"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112997"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac604"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac661"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00832-1"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2022.100153"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27458"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.12.023"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.04.020"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/09612033231151898"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.08.068"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41937"},{"issue":"3","key":"e_1_2_11_43_1","first-page":"676","article-title":"Immunogenicity and Risk of Disease Flare After a Three\u2010Dose Regimen With SARS\u2010CoV\u20102 Vaccination in Patients With Systemic Lupus Erythematosus: Results From the Prospective Cohort Study COVAC\u2010SLE","volume":"41","author":"Larsen E. S.","year":"2023","journal-title":"Clinical and Experimental Rheumatology"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2023-0721"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1191\/096120399680411362"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309345748"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001267"},{"issue":"2","key":"e_1_2_11_48_1","first-page":"288","article-title":"Systemic Lupus Erythematosus Disease Activity Index 2000","volume":"29","author":"Gladman D. D.","year":"2002","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10111408"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109882"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.70001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1756-185X.70001","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.70001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T02:05:26Z","timestamp":1771207526000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.70001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1111\/1756-185X.70001"],"URL":"https:\/\/doi.org\/10.1111\/1756-185x.70001","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-10-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70001"}}